Final ID: Wed129
Lee Kwonjae, Del Rio Carlos, Mcnally Elizabeth, Pfenniger Anna, Bhatnagar Ashita, Glinton Kristofor, Burrell Amy, Ober Rebecca, Mcluckie Alicia, Bishop Brian, Rogers Christopher, Geist Gail
37,500 man-years of clinical expertise validate the cardio-metabolic benefits of empagliflozin-linagliptin in type 2 diabetes: findings from the amplified consensusNair Tiny, Jabbar P, Ray Saumitra, Hazra Prakash, Gupta Sushil, Joshi Ameya, Shaikh Shehla, B Jayagopal, Pandit Kaushik, Sharma D, Seshadri Krishna, S Sridhar